Scopien Signs Deal to Take Control of Cannabis Strategic Ventures

• Scopien Technologies signed a binding letter of intent to acquire voting control of Cannabis Strategic Ventures and contribute its operating business.
• Control would pass through the transfer of Series B Super Voting Preferred Stock, with closing targeted for November 30, 2026.
• Scopien, an AI-enabled business software platform, would appoint the company’s officers and directors at closing.
• The company terminated its September 10, 2026, non-binding agreement to acquire substantially all Adport intellectual property and operating assets.
• Plans include completing audits and filing a registration statement within six months of closing, targeting an eventual Nasdaq or NYSE listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cannabis Strategic Ventures published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030900PRIMZONEFULLFEED9868322) on November 03, 2026, and is solely responsible for the information contained therein.